Setting maximum limits for toxic constituents in cigarette smoke

World Health Organization - Technical Report Series

Volumn , Issue 945, 2007, Pages 77-97

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CIGARETTE SMOKE; METAL; NICOTINE; NITROSAMINE; TAR; VOLATILE AGENT;

CIGARETTE SMOKING; CONFERENCE PAPER; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; PARTICULATE MATTER; RISK FACTOR; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 34548261487     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (21)

1. Stratton K et al., eds. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC, National Academy Press, 2001.
2. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda, MD, United States Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2001 (Smoking and Tobacco Control Monograph No. 13) (http://news.findlaw.com/hdocs/ docs/tobacco/nihnci112701cigstdy.pdf, accessed 2 March 2007).
3. WHO Scientific Advisory Committee on Tobacco Product Regulation. Conclusions and recommendations on health claims derived from ISO/FTC method to measure cigarette yield. Geneva, World Health Organization, 2002.
4. Report of "tar", nicotine, and carbon monoxide of the smoke of 1294 varieties of domestic cigarettes for the year 1998. Washington, DC, Federal Trade Commission, 2000 (http://www.ftc.gov/reports/tobacco/ 1998tar&nicotinereport.pdf, accessed 2 March 2007).
5. Hatsukami DK et al. Methods to assess potential reduced exposure products. Nicotine and Tobacco Research, 2005, 7:827-844.
6. Hatsukami DK et al. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine and Tobacco Research, 2006, 8:169-191.
7. WHO Study Group on Tobacco Product Regulation. Guiding principles for the development of tobacco product research and testing capacity and proposed protocols for the initiation of tobacco product testing: recommendation 1. Geneva, World Health Organization, 2004.
8. Smoking methods for cigarettes. International Organization for Standardization, 2006 (ISO/TC 126/WG 9).
9. Counts ME et al. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regulatory Toxicology and Pharmacology, 2005, 41:185-227.
10. Tobacco smoke and involuntary smoking (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans), IARC Monograph 83. Lyon, France, International Agency for Research on Cancer, World Health Organization, 2004.
11. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control, 2003, 12:424-430.
12. Dybing E et al. T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity. Pharmacology & Toxicology, 1997, 80:272-279.
13. Dybing E et al. Hazard characterisation of chemicals in food and diet: dose-response, mechanisms and extrapolation issues. Food and Chemical Toxicology, 2002, 40:237-282.
14. Peele DM, Riddick MG, Edwards ME. Formation of tobacco-specific nitrosamines in flue-cured tobacco. Recent Advances in Tobacco Science, 2001, 27:3-12.
15. Cogliano V et al. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncology, 2004, 5:708.
16. Constituents and emissions reported for cigarettes sold in Canada - 2004. Health Canada, Tobacco Control Programme (http://www.hc-sc.gc.ca/hl-vs/tabac- tabac/legislation/reg/indust/constitu_e.html, accessed 2 March 2007).
17. Australian cigarette emissions data. 2001. Commonwealth Department of Health and Ageing, Australian Government, 2002 (http://www.health.gov.au/ internet/wcms/publishing.nsf/Content/health-pubhlth-strateg-drugs-tobacco- emis_data.htm, accessed 2 March 2007).
18. WHO Scientific Advisory Committee on Tobacco Product Regulation. Statement of principles guiding the evaluation of new or modified tobacco products. Geneva, World Health Organization, 2003.
19. WHO Study Group on Tobacco Product Regulation. Guiding principles for the development of tobacco product research and testing capacity and proposed protocols for the initiation of tobacco product testing: recommendation 1. Geneva, World Health Organization, 2004, p. 16.
20. Wu W, Ashley D, Watson C. Simultaneous determination of 5 tobacco-specific nitrosamines in mainstream cigarette smoke by isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry. Analytical Chemistry, 2003, 75:4827-4832.
21. Data available at http://www.qp.gov.be.ca/statreg/reg/T/TobaccoSales/ 282_98.htm#schedulea, accessed 2 March 2007.